Gliquidone
From Self-sufficiency
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
| File:Gliquidone.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
N-(cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzenesulfonamide | |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Excretion | 95% Biliary, 5% Renal |
| Identifiers | |
| CAS Number | 33342-05-1 |
| ATC code | A10BB08 (WHO) |
| PubChem | CID 91610 |
| Chemical data | |
| Formula | C27H33N3O6S |
| Molar mass | 527.634 g/mol[[Script error: No such module "String".]] |
| (verify) | |
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehriger Ingelheim, Germany.
| 45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from December 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Sulfonylureas
- Isoquinolines
- Imides
- Phenol ethers
- Gastrointestinal system drug stubs
- 2Fix
